Stay updated on Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial

Sign up to get notified when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The record for the Phase Ib study of sublingual dexmedetomidine for agitation associated with schizophrenia is now displayed instead of an access-error page. It provides the trial details and confirms that the study is completed and no longer recruiting.
    Difference
    52%
    Check dated 2026-11-08T06:35:30.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The study record area displays a 403 Forbidden message and a Home link where the prior page showed no record content. The site revision label also changed from v3.7.2 to v3.8.0.
    Difference
    0.6%
    Check dated 2026-11-01T04:37:03.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition appears above the study page. The study record itself remains unavailable and displays a 403 error.
    Difference
    1%
    Check dated 2026-10-25T06:52:05.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T05:21:12.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer’s displayed ClinicalTrials.gov revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T08:30:00.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error page, replacing the previous content with an access-denied view. A Home button is presented on the error page.
    Difference
    0.5%
    Check dated 2026-09-27T07:51:02.000Z thumbnail image

Stay in the know with updates to Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sublingual Dexmedetomidine in Schizophrenia-Associated Agitation Clinical Trial page.